Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
April 29, 1999
Intracoronary shunt insertion prevents myocardial stunning in a juvenile porcine MIDCAB model absent of coronary artery disease
O E Dapunt, M R Raji, S Jeschkeit, et al.
Transplantation Proceedings
|
April 26, 2005
C0h/C2h monitoring of the pharmacodynamics of cyclosporin plus mycophenolate mofetil in human heart transplant recipients
M J Barten, A Rahmel, J Garbade, et al.
Transplantation Proceedings
|
January 3, 2006
Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients
M J Barten, A Rahmel, J Garbade, et al.
Heart (British Cardiac Society)
|
January 20, 2005
Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies
U Wetzel, A Boldt, J Lauschke, et al.
European Journal of Clinical Investigation
|
August 14, 2009
Postoperative development of aspirin resistance following coronary artery bypass
J Kempfert, K Anger, A Rastan, et al.
The Thoracic and Cardiovascular Surgeon
|
March 9, 2011
Activation of cardiomyocytes depending on their proximity to human bone marrow stem cells
F Roeske, A Stein, A Salameh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 15, 2005
Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression
A Salameh, C Frenzel, A Boldt, et al.
Journal of the American College of Cardiology
|
August 31, 2001
Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria
L Polontchouk, J A Haefliger, B Ebelt, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
October 31, 2008
Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure
H-J Schneider, O Husser, M Rihm, et al.
Pharmacogenetics
|
May 8, 2001
In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans
R Büscher, H Belger, K J Eilmes, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
April 29, 1999
Intracoronary shunt insertion prevents myocardial stunning in a juvenile porcine MIDCAB model absent of coronary artery disease
O E Dapunt, M R Raji, S Jeschkeit, et al.
Transplantation Proceedings
|
April 26, 2005
C0h/C2h monitoring of the pharmacodynamics of cyclosporin plus mycophenolate mofetil in human heart transplant recipients
M J Barten, A Rahmel, J Garbade, et al.
Transplantation Proceedings
|
January 3, 2006
Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients
M J Barten, A Rahmel, J Garbade, et al.
Heart (British Cardiac Society)
|
January 20, 2005
Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies
U Wetzel, A Boldt, J Lauschke, et al.
European Journal of Clinical Investigation
|
August 14, 2009
Postoperative development of aspirin resistance following coronary artery bypass
J Kempfert, K Anger, A Rastan, et al.
The Thoracic and Cardiovascular Surgeon
|
March 9, 2011
Activation of cardiomyocytes depending on their proximity to human bone marrow stem cells
F Roeske, A Stein, A Salameh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 15, 2005
Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression
A Salameh, C Frenzel, A Boldt, et al.
Journal of the American College of Cardiology
|
August 31, 2001
Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria
L Polontchouk, J A Haefliger, B Ebelt, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
October 31, 2008
Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure
H-J Schneider, O Husser, M Rihm, et al.
Pharmacogenetics
|
May 8, 2001
In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans
R Büscher, H Belger, K J Eilmes, et al.
Page
of 9